Browsing: biosimilar drugs

Samsung Bioepis has just reached a thrilling milestone by securing Japan’s regulatory approval for its Stelara biosimilar, opening the door to a powerful presence in Asia’s rapidly growing biologics market, The Korea Herald reports

Celltrion USA is excited to announce the U.S. debut of its denosumab biosimilars, STOBOCLO® and OSENVELT® (denosumab-bmwo), offering innovative and powerful new solutions for osteoporosis and bone health management